Diabetes Advocate and Opinion Leader David Edelman Joins LabStyle Innovations as Product Strategy Director
LabStyle on track with 2014 global roll-out plans for the Dario™ diabetes management platform
RAMAT GAN, Israel, Dec. 18, 2013 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of Dario™, a cloud-based, mobile health platform for diabetes and blood glucose monitoring, announced that diabetes advocate and opinion leader David Edelman has joined the company as the new director of product strategy. He is also the newest member of the company's scientific advisory board (SAB).
Mr. Edelman is the co-founder and president of Diabetes Daily, a leading diabetes online community with over four million annual visitors. The influential website features a diabetes magazine, community forums, and an original recipe collection. Mr. Edelman also sits on the Board of Advisors of the Diabetes Hands Foundation. He is the November 2013 recipient of the Social HealthMaker in Diabetes award.
"Through the years, I've engaged with tens of thousands of people living with diabetes, learned their hopes, fears, struggles, and successes. I have discovered that there are a lot of things broken with how we treat diabetes, and I believe that the introduction of Dario™ represents an important step towards fixing them," said Mr. Edelman. "I am a big believer in LabStyle's mission of helping people manage diabetes through building a smarter treatment platform. It is a pleasure to work with a smart and passionate team on such an ambitious vision to improve the lives of millions living with diabetes."
Mr. Edelman will be helping LabStyle focus on innovating beyond merely tracking diabetes. "Some of the most innovative products, which will soon be able to sync with smart phones, are still too focused on tracking. Getting data into a smart phone, and more importantly, a cloud environment, is just the first step in a journey to transform care. Real change comes when you use that platform to help patients identify patterns, proactively recommend treatment changes, and support behavior change efforts. It's enhanced when you enable doctors to better identify patients at high-risk, to make, more frequently, better and faster clinical decisions, and to more easily, routinely follow-up. It also accelerates when health systems can automatically target resources to patients who are most likely to have acute or long-term complications," said Mr. Edelman.
Mr. Erez Raphael, LabStyle's president and chief executive officer, agreed, "A smartphone-powered meter is the cornerstone of an ambitious program to not only provide the best tracking solution, but also the best health outcome improvement system. This is why we are in high-level talks with potential partners to expand our current solution to support medical practices, hospital systems and payers. We believe that our comprehensive vision, speed of development, and commitment to bringing together third-party device and software companies under one platform, will make Dario™ the most appealing solution for those in healthcare."
With the intention of providing the best and most useful diabetes management platform possible, LabStyle regularly turns to patients, physicians and experts in the diabetes community with a genuine interest in learning about concerns, challenges and unmet needs. Mr. Raphael continued, "This ongoing feedback helps us to better understand what is required to improve diabetes care and is proactively applied to increase the abilities and the deliverables of the Dario™ diabetes management platform for the benefit of diabetes community. David Edelman's vast experience, respected leadership, and clear understanding of the hurdles faced by the diabetes community will certainly help us remain focused on what matters most. We are well aligned, and look forward to doing great things together. We warmly welcome David to the LabStyle team, both in his role as product strategy director and as a contributor on our SAB."